NX
NextCure, Inc.
NXTC · NASDAQ
$6.02 +2.56% (+$0.15)
1M -2.70%
Market Cap $20.1M
P/E Ratio -
Div. Yield -
ROE 175.46%
Bulios Fair Price
$8.77
45.7% upside
Trenutna cena
$6.02
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NXTC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
96 /100
Cheap P/B 1.65x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 40.70%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 175.46%
ROA 188.98%
Asset turnover 0.00x
Debt
97 /100
Low Current ratio 3.47x
Debt/Equity 0.35x
Net debt/EBITDA N/A
Stability
61 /100
Moderate EPS volatility 3.16%
Profitable years 0
Beta 1.34x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NXTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael S. Richman
Employees
40
Headquarters
Beltsville
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report